Politics States Economy Society Business Culture Infra Defence World Books Ideas Science Technology Heritage Archives Legal Movies Sports

Our Views
Politics States Economy Society Business Culture Infra Defence World Books Ideas Science Technology Heritage Archives Legal Movies Sports
Magazine
Store

About Swarajya

Swarajya is a publication by Kovai Media Private Limited.

Swarajya - a big tent for liberal right of centre discourse that reaches out, engages and caters to the new India.

editor@swarajyamag.com

Useful Links

About Us
Subscriptions Support
Editorial Philosophy
Press Kit

Privacy Policy
Terms of Use
Code of Conduct
Plagiarism Policy
Refund & Cancellation Policy

Useful Links

About Us
Subscriptions Support
Editorial Philosophy
Press Kit

Privacy Policy
Terms of Use
Code of Conduct
Plagiarism Policy
Refund & Cancellation Policy

Participate

Contact Us
Write for us
Style Guide
Jobs

Stay Connected

J%26J

Johnson & Johnson Announces Separation Of Businesses: Details You Need To Know

Bhaswati Guha Majumder

Johnson & Johnson

J&J Seeks Approval For Clinical Trials Of Its Single-Shot COVID-19 Vaccine On Adolescents Aged 12-17 Years In India

J&J Covid-19 vaccine

J&J's Single-Shot COVID-19 Vaccine Becomes Fifth Jab To Get Approval For Emergency Use In India

(A picture of vaccine vials from Johnson and Johnson)

US Pharma Major J&J Seeks Emergency Use Approval For Its Single-Shot COVID-19 Vaccine In India

(A picture of vaccine vials from Johnson and Johnson)

AHPI Close To Striking A Deal For Import Of J&J's Single-Dose COVID-19 Vaccine Into India Early Next Month

J&J

Bullish Scenario For Vaccine Rollout: How India Might Achieve Herd Immunity By Dussehra

Covid-19 vaccine. (Representative image)

Covid-19 Vaccine Could Be Ready By October End, Claims Pharma Major Pfizer’s CEO

Double Trouble For Johnson & Johnson: After Asbestos Panic, Now It’s Faulty Hip Transplants

Representative image (Unsplash/Jafar Ahmed)

Get Swarajya in your inbox.